Chemoinformaics analysis of 5-Hydroxypentanal
| Molecular Weight | 102.133 | nRot | 4 |
| Heavy Atom Molecular Weight | 92.053 | nRig | 1 |
| Exact Molecular Weight | 102.068 | nRing | 0 |
| Solubility: LogS | 0.789 | nHRing | 0 |
| Solubility: LogP | -0.561 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 16.6219 |
| nHD | 1 | BPOL | 10.9001 |
| QED | 0.41 |
| Synth | 2.354 |
| Natural Product Likeliness | 2.365 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.077 |
| Pgp-sub | 0.032 |
| HIA | 0.01 |
| CACO-2 | -4.288 |
| MDCK | 0.0000309 |
| BBB | 0.375 |
| PPB | 0.276671 |
| VDSS | 0.872 |
| FU | 0.854168 |
| CYP1A2-inh | 0.039 |
| CYP1A2-sub | 0.379 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.227 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.166 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.125 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.139 |
| CL | 7.624 |
| T12 | 0.851 |
| hERG | 0.085 |
| Ames | 0.258 |
| ROA | 0.051 |
| SkinSen | 0.954 |
| Carcinogencity | 0.032 |
| EI | 0.994 |
| Respiratory | 0.823 |
| NR-Aromatase | 0.037 |
| Antiviral | No |
| Prediction | 0.940942 |